Drug recall · October 22, 2014
Lidocaine HCl Injection recall
Why: Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and Nerve Block including Epidural and Caudal, Manufactured by: Hospira, Inc., Lake Forest, IL, 60045, NDC 0409-2066-05
- Lots / codes
Lot Number: 25-550-DD, Exp: 1JAN2015
- Quantity
- 109,110 Vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- July 29, 2014 · Voluntary: Firm initiated
- Classified
- October 10, 2014
- Reported
- October 22, 2014
- Ended
- March 17, 2017
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.